https://doi.org/10.4081/ejtm.2022.10582
Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients
Submitted: 30 April 2022
Accepted: 21 May 2022
Published: 20 June 2022
Accepted: 21 May 2022
Abstract Views: 830
PDF: 423
HTML: 4
HTML: 4
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
We aimed to review the records of cancer and kidney transplant patients of out of 1135 COVID-19 patients, who were referred to our hospital (Valiasr) in Zanjan, from March 16th, 2020, to June 11th, 2020. This was single-center, historical cohort study. Patients were divided into different subgroups and compared of disease outcomes. The only predictor of death was lactate dehydrogenase (LDH). The rate of red cell distribution width (RDW) in patients with active cancer was higher than kidney transplant patients and was statistically significant. There was no statistically significant difference in mortality between active and non-active cancer groups. Female sex and low SpO2 has increased the chances of ICU admission. Patients with active cancer generally have severe and more complicated disease and RDW can be a predictable option.
Moradzadeh R, Jamalian SM, Nazari J, Kamali A, Sadeghi B, Hosseinkhani Z, Sofian M, Zamanian M. Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran. J Educ Health Promot. 2021 May 31;10(1):169.
DOI: https://doi.org/10.31032/IJBPAS/2021/10.4.5465A
Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, Pan D, Shu C, Li J, Wei J, Huang Y, Peng L, Wu M, Zhang R, Wu B, Li Y, Cai L, Li G, Zhang T, Wu G. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020 Jul;21(7):904-913. Epub 2020 May 29.
DOI: https://doi.org/10.1016/S1470-2045(20)30310-7
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, Xiong Y, Xiong H, Wang C, Chen C, Xiong F, Zhang Y, Peng Y, Ge S, Zhen B, Yu T, Wang L, Wang H, Liu Y, Chen Y, Mei J, Gao X, Li Z, Gan L, He C, Li Z, Shi Y, Qi Y, Yang J, Tenen DG, Chai L, Mucci LA, Santillana M, Cai H. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020 Jun;10(6):783-791. Epub 2020 Apr 28.
DOI: https://doi.org/10.1158/2159-8290.CD-20-0422
Maschmeyer G, De Greef J, Mellinghoff SC, Nosari A, Thiebaut-Bertrand A, Bergeron A, Franquet T, Blijlevens NMA, Maertens JA; European Conference on Infections in Leukemia (ECIL). Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia. 2019 Apr;33(4):844-862. Epub 2019 Jan 30.
DOI: https://doi.org/10.1038/s41375-019-0388-x
Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, Ross M, Forest S, Goldstein YD, Ajaimy M, Liriano-Ward L, Pynadath C, Loarte-Campos P, Nandigam PB, Graham J, Le M, Rocca J, Kinkhabwala M. Covid-19 and Kidney Transplantation. N Engl J Med. 2020 Jun 18;382(25):2475-2477. Epub 2020 Apr 24.
DOI: https://doi.org/10.1056/NEJMc2011117
Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, Maffei C, Possenti S, Zambetti N, Moscato M, Venturini M, Affatato S, Gaggiotti M, Bossini N, Scolari F. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. 2020 Jun;97(6):1083-1088. Epub 2020 Apr 9.
DOI: https://doi.org/10.1016/j.kint.2020.04.002
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020 Jun;99(6):1205-1208. Epub 2020 Apr 15.
DOI: https://doi.org/10.1007/s00277-020-04019-0
Lippi G, Henry BM, Sanchis-Gomar F. Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019. Acta Haematol. 2021;144(4):360-364. Epub 2020 Aug 25.
DOI: https://doi.org/10.1159/000510914
Wang B, Gong Y, Ying B, Cheng B. Relation between Red Cell Distribution Width and Mortality in Critically Ill Patients with Acute Respiratory Distress Syndrome. Biomed Res Int. 2019 Mar 21;2019:1942078.
DOI: https://doi.org/10.1155/2019/1942078
Alkhatib A, Price LL, Esteitie R, LaCamera P. A Predictive Model for Acute Respiratory Distress Syndrome Mortality Using Red Cell Distribution Width. Crit Care Res Pract. 2020 Jan 4;2020:3832683.
DOI: https://doi.org/10.1155/2020/3832683
Gao Y, Chen Y, Liu M, Shi S, Tian J. Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis. J Infect. 2020 Aug;81(2):e93-e95. Epub 2020 May 15.
DOI: https://doi.org/10.1016/j.jinf.2020.05.017
Fung M, Babik JM. COVID-19 in Immunocompromised Hosts: What We Know So Far. Clin Infect Dis. 2021 Jan 27;72(2):340-350.
DOI: https://doi.org/10.1093/cid/ciaa863
Güçlü E, Kocayiğit H, Okan HD, Erkorkmaz U, Yürümez Y, Yaylacı S, Koroglu M, Uzun C, Karabay O. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras (1992). 2020 Aug;66(8):1122-1127.
DOI: https://doi.org/10.1590/1806-9282.66.8.1122
Liu H, Yang D, Chen X, Sun Z, Zou Y, Chen C, Sun S. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis. Cancer Med. 2021 Feb;10(3):1043-1056. Epub 2020 Dec 31.
DOI: https://doi.org/10.1002/cam4.3692
Lee LY, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, Chackathayil J, Cheng VW, Curley HM, Fittall MW, Freeman-Mills L, Gennatas S, Goel A, Hartley S, Hughes DJ, Kerr D, Lee AJ, Lee RJ, McGrath SE, Middleton CP, Murugaesu N, Newsom-Davis T, Okines AF, Olsson-Brown AC, Palles C, Pan Y, Pettengell R, Powles T, Protheroe EA, Purshouse K, Sharma-Oates A, Sivakumar S, Smith AJ, Starkey T, Turnbull CD, Várnai C, Yousaf N; UK Coronavirus Monitoring Project Team, Kerr R, Middleton G. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020 Jun 20;395(10241):1919-1926. Epub 2020 May 28. Erratum in: Lancet. 2020 Aug 22;396(10250):534.
DOI: https://doi.org/10.1016/S0140-6736(20)31173-9
Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, Martín-Moro F, Razanamahery J, Riches JC, Zwicker J, Patell R, Vekemans MC, Scarfò L, Chatzikonstantinou T, Yildiz H, Lattenist R, Mantzaris I, Wood WA, Hicks LK. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020 Dec 17;136(25):2881-2892.
DOI: https://doi.org/10.1182/blood.2020008824
Shoumariyeh K, Biavasco F, Ihorst G, Rieg S, Nieters A, Kern WV, Miething C, Duyster J, Engelhardt M, Bertz H. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany. Cancer Med. 2020 Nov;9(22):8412-8422. Epub 2020 Sep 15.
DOI: https://doi.org/10.1002/cam4.3460
Ma J, Yin J, Qian Y, Wu Y. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study. J Infect. 2020 Aug;81(2):318-356. Epub 2020 Apr 14.
DOI: https://doi.org/10.1016/j.jinf.2020.04.006
Cavanna L, Citterio C, Di Nunzio C, Biasini C, Palladino MA, Ambroggi M, Madaro S, Bidin L, Porzio R, Proietto M. Prevalence of COVID-19 Infection in Asymptomatic Cancer Patients in a District With High Prevalence of SARS-CoV-2 in Italy. Cureus. 2021 Mar 9;13(3):e13774.
DOI: https://doi.org/10.7759/cureus.13774
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30.
DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021 Mar 30;11(3):e048391.
Sharma D, Dayama A, Banerjee S, Bhandhari S, Chatterjee A, Chatterjee D. To Study the Role of Absolute Lymphocyte Count and RDW in COVID 19 Patients and their Association with Appearance of Symptoms and Severity. J Assoc Physicians India. 2020 Aug;68(8):39-42.
Allameh SF, Nemati S, Ghalehtaki R, Mohammadnejad E, Aghili SM, Khajavirad N, Beigmohammadi MT, Salehi M, Mirfazaelian H, Edalatifard M, Kazemizadeh H, Dehghan Manshadi SA, Hasannezhad M, Amoozadeh L, Radnia M, Khatami SR, Nahvijou A, Seyyedsalehi MS, Rashidian L, Ayoobi Yazdi N, Nasiri Toosi M, Sadeghniiat-Haghighi K, Jafarian A, Yunesian M, Zendehdel K. Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran. Arch Iran Med. 2020 Nov 1;23(11):766-775.
DOI: https://doi.org/10.34172/aim.2020.102
How to Cite
Moghimi, M., Jozpanahi, M., Khodadadi, K., Saeed, S. P., Pirsaraie, S. V. A., & Jalili, N. (2022). Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients. European Journal of Translational Myology, 32(2). https://doi.org/10.4081/ejtm.2022.10582
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.